Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study

Karolinska Institutet1 site in 1 country17 target enrollmentMarch 2014

ConditionsNonsuicidal Self-Injury

Overview

Phase: N/A
Intervention: Not specified
Conditions: Nonsuicidal Self-Injury
Sponsor: Karolinska Institutet
Enrollment: 17
Locations: 1
Primary Endpoint: Deliberate Self-Harm Inventory - 9 item version
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy for Adolescents (ERITA) who self-harm.

Registry

clinicaltrials.gov

Start Date

March 2014

End Date

January 2016

Last Updated

10 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Karolinska Institutet

Responsible Party

Principal Investigator

Clara Hellner Gumpert

PhD

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

•a primary diagnosis of NSSI as defined by DSM-5 Section 3
•\< 1 NSSI episode during the past month
•at least one parent needs to commit to participate in the parent program

Exclusion Criteria

•bipolar disorder I or primary psychosis
•severe suicidal ideation
•ongoing substance dependence
•Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment
•other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand
•current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse)
•insufficient Swedish language skills
•Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)

Outcomes

Primary Outcomes

Deliberate Self-Harm Inventory - 9 item version

Time Frame: Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up

Change from baseline in self-harming behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended.

Secondary Outcomes

Evaluation of the Drug Use Disorders Identification Test - C (DUDIT-C)(Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up)
Borderline Symptom List Behavior supplement (BSL-supplement)(Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up)
Difficulties in Emotion Regulation Scale -16 item version (DERS-16)(Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up)
Diary questionnaire (DQ)(Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up)
Difficulties in Emotion Regulation Scale (DERS)(Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up)
Strengths and Difficulties Questionnaire Child and Parent version (SDQ-C/P)(Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up)
Borderline personality features in childhood (BPFS-C)(Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up)
The alcohol use disorders identification test - C (AUDIT-C)(Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up)